| [2] |
Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases [J]. BMC Immunol, 2017, 18(1): 2.
|
| [3] |
Xu Z, Knight R. Dietary effects on human gut microbiome diversity [J]. Br J Nutr, 2015, 113 Suppl(Suppl0): S1-S5.
|
| [4] |
Liang Q, Chiu J, Chen Y, et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer [J]. Clin Cancer Res, 2017, 23(8): 2061-2070.
|
| [5] |
Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get [J]. Protein Cell, 2018, 9(5): 474-487.
|
| [6] |
O'Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer [J]. Nat Rev Gastroenterol Hepatol, 2016, 13(12): 691-706.
|
| [7] |
Tjalsma H, Boleij A, Marchesi JR, et al. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects [J]. Nat Rev Microbiol, 2012, 10(8): 575-582.
URL
|
| [8] |
Beyer-Sehlmeyer G, Glei M, Hartmann E, et al. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources [J]. Br J Nutr, 2003, 90(6): 1057-1070.
|
| [9] |
Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut [J]. Mucosal Immunol, 2017, 10(1): 18-26.
|
| [10] |
赵日升，曹蕾，于君. 无菌鼠模型在结直肠癌研究中的应用 [J]. 中国实验动物学报, 2017, 25(6): 658-662.
|
| [11] |
Ding C, Tang W, Fan X, et al. Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics [J]. Onco Targets Ther, 2018, 11: 4797-4810.
|
| [12] |
Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut [J]. Mucosal Immunol, 2017, 10(1): 18-26.
|
| [13] |
Zackular JP, Baxter NT, Chen GY, et al. Manipulation of the gut microbiota reveals role in colon tumorigenesis [J]. mSphere, 2015, 1(1): e00001-15.
|
| [14] |
Zackular JP, Baxter NT, Iverson KD, et al. The gut microbiome modulates colon tumorigenesis [J]. mBio, 2013, 4(6): e00692-13.
|
| [15] |
Pickard JM, Zeng MY, Caruso R, et al. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease [J]. Immunol Rev, 2017, 279(1): 70-89.
|
| [16] |
Han S, Gao J, Zhou Q, et al. Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review [J]. Cancer Manag Res, 2018, 10: 199-206.
|
| [17] |
Romani L, Zelante T, Palmieri M, et al. The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism [J]. Semin Immunopathol, 2015, 37(2): 163-171.
|
| [18] |
杨佳，于君. 饮食、肠道微生态与结直肠癌 [J/CD]. 中华结直肠疾病电子杂志, 2019, 8(6): 541-545.
|
| [19] |
Ribel-Madsen A, Ribel-Madsen R, Brøns C, et al. Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men [J]. Physiol Rep, 2016, 4(19): e12977.
|
| [20] |
Kim MH, Kang SG, Park JH, et al. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice [J]. Gastroenterology, 2013, 145(2): 396-406.
URL
|
| [21] |
Bindels LB, Porporato P, Dewulf EM, et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver [J]. Br J Cancer, 2012, 107(8): 1337-1344.
|
| [22] |
Lewis K, Lutgendorff F, Phan V, et al. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate [J]. Inflamm Bowel Dis, 2010, 16(7): 1138-1148.
|
| [23] |
Peng L, Li ZR, Green RS, et al. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers [J]. J Nutr, 2009, 139(9): 1619-1625.
|
| [24] |
Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells [J]. Nature, 2013, 504(7480): 446-450.
URL
|
| [25] |
Ryan M, Kochunov P, Rowland LM, et al. Lipid Metabolism, Abdominal Adiposity, and Cerebral Health in the Amish [J]. Obesity (Silver Spring), 2017, 25(11): 1876-1880.
|
| [26] |
Giang TM, Gaucel S, Brestaz P, et al. Dynamic modeling of in vitro lipid digestion: individual fatty acid release and bioaccessibility kinetics [J]. Food Chem, 2016, 194: 1180-1188.
|
| [27] |
Shen C, Xue M, Qiu H, et al. Insertion of neurotransmitters into a lipid bilayer membrane and its implication on membrane stability: a molecular dynamics study [J]. Chemphyschem, 2017, 18(6): 626-633.
|
| [28] |
Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer [J].Gut Microbes, 2016, 7(3): 201-215.
|
| [29] |
Savari S, Vinnakota K, Zhang Y, et al. Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer [J].World J Gastroenterol, 2014, 20(4): 968-977.
|
| [30] |
Wang D, DuBois RN. An inflammatory mediator, prostaglandin E2, in colorectal cancer [J].Cancer J, 2013, 19(6): 502-510.
URL
|
| [31] |
Kai M, Yamamoto E, Sato A, et al. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer [J].Mol Carcinog, 2017, 56(7): 1743-1752.
|
| [32] |
Ma N, Tian Y, Wu Y, et al. Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health [J].Curr Protein Pept Sci, 2017, 18(8): 795-808.
|
| [33] |
Espejo-Herrera N, Gràcia-Lavedan E, Boldo E, et al. Colorectal cancer risk and nitrate exposure through drinking water and diet [J].Int J Cancer, 2016, 139(2): 334-346.
|
| [1] |
Leystra AA, Clapper ML. Gut microbiota influences experimental outcomes in mouse models of colorectal cancer [J]. Genes (Basel), 2019, 10(11): 900.
|
| [34] |
Bingham SA, Pignatelli B, Pollock JR, et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? [J].Carcinogenesis, 1996, 17(3): 515-523.
|
| [35] |
Yang T, Owen JL, Lightfoot YL, et al. Microbiota impact on the epigenetic regulation of colorectal cancer [J].Trends Mol Med, 2013, 19(12): 714-725.
|
| [36] |
Kumar M, Nagpal R, Verma V, et al. Probiotic metabolites as epigenetic targets in the prevention of colon cancer [J].Nutr Rev, 2013, 71(1): 23-34.
|
| [37] |
Ohgaki H, Kusama K, Matsukura N, et al. Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract [J].Carcinogenesis, 1984, 5(7): 921-924.
|
| [38] |
Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function [J]. Aliment Pharmacol Ther, 2008, 27(2):104-119.
|
| [39] |
Fung KY, Cosgrove L, Lockett T, et al. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate [J]. Br J Nut, 2012, 108(5): 820-831.
|
| [40] |
Beaumont M, Portune KJ, Steuer N, et al. Quantity and source of dietary protein influence metabolite production by gut microbiota and rectal mucosa gene expression: a randomized, parallel, double-blind trial in overweight humans [J].Am J Clin Nutr, 2017, 106(4): 1005-1019.
|
| [41] |
Narisawa T, Magadia NE, Weisburger JH, et al. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats [J]. J Natl Cancer Inst, 1974, 53(4): 1093-1097.
|
| [42] |
Liu L, Zhuang W, Wang RQ, et al. Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies [J]. Eur J Nutr, 2011, 50(3): 173-184.
URL
|
| [43] |
Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths [J]. Clin Microbiol Infect, 2005, 11(12): 958-966.
|
| [44] |
Kahouli I, Tomaro-Duchesneau C, Prakash S. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives [J]. J Med Microbiol, 2013, 62(Pt 8): 1107-1123.
|
| [45] |
Hsieh CY, Osaka T, Moriyama E, et al. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum [J]. Physiol Rep, 2015, 3(3): e12327.
|
| [46] |
Blackwood BP, Yuan CY, Wood DR, et al. Probiotic lactobacillus species strengthen intestinal barrier function and tight junction integrity in experimental necrotizing enterocolitis [J]. J Probiotics Health, 2017, 5(1): 159.
|
| [47] |
Mojka K. Probiotics, prebiotics and synbiotics—Characteristics and functions [J]. Probl Hig Epidemiol, 2014, 95: 541-549.
|